Protocol summary

Study aim
Comparison of the effect of non-invasive ventilation (NIV) and Venturi mask on impulse oscillometry (IOS) parameters in hospitalized patients with acute exacerbation of chronic obstructive pulmonary disease (COPD)
Design
A phase 3, randomized, double-blind, parallel-group, clinical trial conducted on 60 patients. Permuted block randomization will be used for randomization.
Settings and conduct
This study is conducted as a clinical trial (double-blind) on hospitalized patients with acute exacerbation of chronic obstructive pulmonary disease visiting Masih Daneshvari Hospital in Tehran. In the NIV group, patients receive non-invasive ventilation with an appropriate mask, and in the Venturi group, they receive oxygen through a Venturi mask.
Participants/Inclusion and exclusion criteria
Inclusion criteria for the study include increased shortness of breath, increased sputum volume or purulence, and oxygen saturation below 88%, arterial blood gas with pH greater than or equal to 7.30 and PaCO₂ greater than or equal to 45 mmHg, and the ability to perform the IOS test. Exclusion criteria include severe acidosis, respiratory arrest or immediate need for intubation, severe hemodynamic instability, need for invasive ventilation, presence of lobar consolidation, active pneumothorax, and very high BMI.
Intervention groups
In the NIV group, patients were placed on non-invasive ventilation with an appropriate mask and positive airway pressure during inspiration (IPAP) of 10–14 cm H2O, positive airway pressure during expiration of 4–6 cm H2O, and the fraction of inspired oxygen was adjusted to a range of 88–92%. In the Venturi group, patients were placed on a Venturi mask with blood oxygen saturation (O2sat) maintained at 88 to 92%.
Main outcome variables
Total airway resistance, central airway resistance, reactivity at 5 Hertz, resonance frequency, reactance area

General information

Reason for update
Acronym
IRCT registration information
IRCT registration number: IRCT20160516027929N13
Registration date: 2026-05-31, 1405/03/10
Registration timing: prospective

Last update: 2026-05-31, 1405/03/10
Update count: 0
Registration date
2026-05-31, 1405/03/10
Registrant information
Name
Atefeh Fakharian
Name of organization / entity
National research institute of tuberculosis and lung diseases
Country
Iran (Islamic Republic of)
Phone
+98 21 2712 2541
Email address
afakharian@sbmu.ac.ir
Recruitment status
Not yet recruiting
Funding source
Expected recruitment start date
2026-07-23, 1405/05/01
Expected recruitment end date
2027-01-21, 1405/11/01
Actual recruitment start date
empty
Actual recruitment end date
empty
Trial completion date
empty
Scientific title
Comparison of the effect of Non-Invasive Ventilation (NIV) and Venturi mask on Impulse Oscillometry (IOS) parameters in hospitalized patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease (COPD)
Public title
Comparison of the effectiveness of non-invasive ventilation and Venturi mask in patients with chronic obstructive pulmonary disease
Purpose
Treatment
Inclusion/Exclusion criteria
Inclusion criteria:
Hospitalized patients with acute exacerbation of chronic obstructive pulmonary disease (COPD) Dyspnea Oxygen saturation (SpO2) less than 88% on room air pH greater than or equal to 7.30 Partial pressure of carbon dioxide (PaCO2) greater than or equal to 45 mmHg in arterial blood gases (ABG) upon admission Appropriate level of consciousness (Glasgow Coma Scale 15) Ability to cooperate and perform Impulse Oscillometry test Informed consent to participate in the study
Exclusion criteria:
Patient's unwillingness to participate in the research study
Age
No age limit
Gender
Both
Phase
3
Groups that have been masked
  • Participant
  • Outcome assessor
Sample size
Target sample size: 60
Randomization (investigator's opinion)
Randomized
Randomization description
The method used is permuted block randomization. For this purpose, two treatment groups, A and B, are defined in blocks as AB and BA. Then, numbers from a random table in the range 0 to 9 are considered. Numbers 0 to 4 are assigned to block AB, and numbers 5 to 9 are assigned to block BA. Random numbers are then selected from the table. If the number 0 appears, it corresponds to block AB, and therefore two individuals enter this block, such that the first individual receives treatment A and the second individual receives treatment B. In the same way, the treatment groups for the remaining participants are determined. Although in this method the number of observations in both groups will be equal, because of the small block sizes, there is a high probability that the person conducting the study may predict the treatment group assignment. To solve this problem, the randomization list is prepared before the start of the study by a blinded individual who is not part of the treatment team. Additionally, the block sizes will be increased.
Blinding (investigator's opinion)
Double blinded
Blinding description
To ensure blinding, patients are placed in separate rooms and are unaware of their group assignment. Additionally, the operator responsible for performing Impulse Oscillometry is different from the nurse who sets up the non-invasive ventilation or Venturi mask for the patient. This operator is blinded to the patient grouping during the Impulse Oscillometry test, which is conducted in a location separate from the intervention site. Furthermore, the data analyst will only have access to coded data (Group A and Group B) and will remain blinded to the nature of the groups until the end of the statistical analysis process.
Placebo
Not used
Assignment
Parallel
Other design features

Secondary Ids

empty

Ethics committees

1

Ethics committee
Name of ethics committee
Ethics committee of School of Medicine, Shahid Beheshti University of Medical Sciences
Street address
Shahid Abbas Arabi Street, Yemen Street, Shahid Chamran Highway
City
Tehran
Province
Tehran
Postal code
1956944413
Approval date
2026-05-05, 1405/02/15
Ethics committee reference number
IR.SBMU.MSP.REC.1405.061

Health conditions studied

1

Description of health condition studied
Chronic obstructive pulmonary disease
ICD-10 code
J44.1
ICD-10 code description
Chronic obstructive pulmonary disease with (acute) exacerbation

Primary outcomes

1

Description
Airway resistance at 5 Hz frequency (R5)
Timepoint
Before the intervention (the first day of hospitalization) and after the intervention (on the fourth day)
Method of measurement
Impulse Oscillometry

2

Description
Airway resistance at 20 Hz frequency (R5)
Timepoint
Before the intervention (the first day of hospitalization) and after the intervention (on the fourth day)
Method of measurement
Impulse Oscillometry

3

Description
Resistance heterogeneity level (R5–R20)
Timepoint
Before the intervention (the first day of hospitalization) and after the intervention (on the fourth day)
Method of measurement
Impulse Oscillometry

4

Description
Input Impedance (X5)
Timepoint
Before the intervention (the first day of hospitalization) and after the intervention (on the fourth day)
Method of measurement
Impulse Oscillometry

5

Description
Resonance frequency (Fres)
Timepoint
Before the intervention (the first day of hospitalization) and after the intervention (on the fourth day)
Method of measurement
Impulse Oscillometry

6

Description
Resonance area (AX)
Timepoint
Before the intervention (the first day of hospitalization) and after the intervention (on the fourth day)
Method of measurement
Impulse Oscillometry

Secondary outcomes

1

Description
Oxygen saturation percentage
Timepoint
Before the intervention (the first day of hospitalization) and after the intervention (on the fourth day)
Method of measurement
Pulse oximetry

2

Description
Peripheral blood eosinophil
Timepoint
Before the intervention (the first day of hospitalization) and after the intervention (on the fourth day)
Method of measurement
Counting of blood cells

3

Description
Number of disease exacerbations
Timepoint
From the beginning of entering the study to the end of the study
Method of measurement
Self-expression

4

Description
Blood acidity (pH)
Timepoint
Before the intervention (the first day of hospitalization) and after the intervention (on the fourth day)
Method of measurement
Venous Blood Gas Analysis

5

Description
Bicarbonate
Timepoint
Before the intervention (the first day of hospitalization) and after the intervention (on the fourth day)
Method of measurement
Venous Blood Gas Analysis

6

Description
Partial pressure of carbon dioxide
Timepoint
Before the intervention (the first day of hospitalization) and after the intervention (on the fourth day)
Method of measurement
Venous Blood Gas Analysis

Intervention groups

1

Description
Intervention group: In the NIV group, patients are placed on non-invasive ventilation with an appropriate mask. The initial device settings will be standard as follows: IPAP: 10–14 cmH₂O EPAP: 4–6 cmH₂O FiO₂ adjustment with the goal of maintaining oxygen saturation (SpO₂) in the range of 88–92% Settings can be adjusted based on patient tolerance, reduction of dyspnea, and improvement of respiratory indices.
Category
Treatment - Other

2

Description
Intervention group: In the Venturi group, patients receive the required oxygen with the following settings: the percentage of the Venturi mask will be determined to maintain O2 saturation at 88 to 92.
Category
Treatment - Other

Recruitment centers

1

Recruitment center
Name of recruitment center
Masih Daneshvari Hospital
Full name of responsible person
Atena Nayebi
Street address
Darabad, Masih Daneshvari Hospital
City
Tehran
Province
Tehran
Postal code
1956944413
Phone
+98 21 2610 9946
Email
atenanayebi@gmail.com

Sponsors / Funding sources

1

Sponsor
Name of organization / entity
Shahid Beheshti University of Medical Sciences
Full name of responsible person
Afshin Zarghi
Street address
Shahid Abbas Arabi Street, Yemen Street, Shahid Chamran Highway
City
Tehran
Province
Tehran
Postal code
1956944413
Phone
+98 21 2243 9781
Email
zarghi@sbmu.ac.ir
Grant name
Grant code / Reference number
Is the source of funding the same sponsor organization/entity?
Yes
Title of funding source
Shahid Beheshti University of Medical Sciences
Proportion provided by this source
100
Public or private sector
Public
Domestic or foreign origin
Domestic
Category of foreign source of funding
empty
Country of origin
Type of organization providing the funding
Academic

Person responsible for general inquiries

Contact
Name of organization / entity
Shahid Beheshti University of Medical Sciences
Full name of responsible person
Mohsen Sadeghi
Position
Assistant professor
Latest degree
Subspecialist
Other areas of specialty/work
Internal Medicine
Street address
Masih Daneshvari Hospital, Darabad
City
Tehran
Province
Tehran
Postal code
1956944413
Phone
+98 21 2610 9946
Email
doctormsadeghi@gmail.com

Person responsible for scientific inquiries

Contact
Name of organization / entity
Shahid Beheshti University of Medical Sciences
Full name of responsible person
Hamidreza Jamaati
Position
Professor
Latest degree
Subspecialist
Other areas of specialty/work
Internal Medicine
Street address
Masih Daneshvari Hospital, Darabad
City
Tehran
Province
Tehran
Postal code
1956944413
Phone
+98 21 2610 2020
Email
hrjamaai@hotmail.com

Person responsible for updating data

Contact
Name of organization / entity
Shahid Beheshti University of Medical Sciences
Full name of responsible person
Atefeh Fakharian
Position
Associate professor
Latest degree
Subspecialist
Other areas of specialty/work
Internal Medicine
Street address
Masih Daneshvari Hospital, Darabad
City
Tehran
Province
Tehran
Postal code
1956944413
Phone
+98 21 2610 9946
Email
fakharian_2005@yahoo.com

Sharing plan

Deidentified Individual Participant Data Set (IPD)
Undecided - It is not yet known if there will be a plan to make this available
Study Protocol
Undecided - It is not yet known if there will be a plan to make this available
Statistical Analysis Plan
Undecided - It is not yet known if there will be a plan to make this available
Informed Consent Form
Undecided - It is not yet known if there will be a plan to make this available
Clinical Study Report
Undecided - It is not yet known if there will be a plan to make this available
Analytic Code
Undecided - It is not yet known if there will be a plan to make this available
Data Dictionary
Undecided - It is not yet known if there will be a plan to make this available
Loading...